Notice of Open Meeting, 62082-62083 [2011-25872]

Download as PDF 62082 Federal Register / Vol. 76, No. 194 / Thursday, October 6, 2011 / Notices MSC 7849, Bethesda, MD 20892, 301–996– 7702, jacobsonrh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Epidemiology. Date: October 27–28, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Denise Wiesch, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3150, MSC 7770, Bethesda, MD 20892, (301) 435– 0684, wieschd@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) September 29, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25877 Filed 10–5–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings mstockstill on DSK4VPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel, Neurodevelopment and Neurodegeneration. Date: October 25–27, 2011. Time: 1 p.m. to 1 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Joanne T Fujii, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4184, MSC 7850, Bethesda, MD 20892, (301) 435– 1178, fujiij@csr.nih.gov. VerDate Mar<15>2010 16:07 Oct 05, 2011 Jkt 226001 Name of Committee: Center for Scientific Review Special Emphasis Panel, Member Conflict: Risk, Prevention and Health Behavior. Date: October 26, 2011. Time: 2:30 p.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Claire E Gutkin, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3106, MSC 7808, Bethesda, MD 20892, 301–594– 3139, gutkincl@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel, AREA applications in Child and Adult Psychopathology, Cognition, and Aging. Date: November 1–2, 2011. Time: 9 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Maribeth Champoux, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3170, MSC 7848, Bethesda, MD 20892, 301–594– 3163, champoum@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: September 28, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25875 Filed 10–5–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the Board of Scientific Counselors for Clinical Sciences and Epidemiology National Cancer Institute. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors for Clinical Sciences and Epidemiology, National Cancer Institute. Date: November 14, 2011. Time: 8:30 a.m. to 4 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, National Cancer Institute, 9000 Rockville Pike, Building 31, Conference Room 10, Bethesda, MD 20892. Contact Person: Brian E. Wojcik, PhD., Senior Review Administrator, Institute Review Office, Office of the Director, National Cancer Institute, 6116 Executive Boulevard, Room 2201, Bethesda, MD 20892, (301) 496–7628, wojcikb@mail.nih.gov. In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/bsc/cse/ cse.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: September 30, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25873 Filed 10–5–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Notice of Open Meeting Notice is hereby given that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a research institute of the National Institutes of Health (NIH), Department of Health and Human Services (DHHS), plans to hold a scientific meeting. Title: ‘‘Meeting on Measurement of Urinary Symptoms (MOMUS).’’ Dates: November 14–15, 2011. E:\FR\FM\06OCN1.SGM 06OCN1 Federal Register / Vol. 76, No. 194 / Thursday, October 6, 2011 / Notices Time: 8:30 a.m.–6 p.m. Place: Building 45, Natcher Center Main Auditorium, NIH campus, Bethesda, MD. Meeting Objectives: A. Discuss the uses and shortcomings of current symptom-based instruments in research of lower urinary tract dysfunction (LUTD). B. Disseminate state-of-the-art methodology to improve patient reported outcomes (PRO) of symptomatic LUTD. C. Discuss the validation and qualification process of new measurement tools, and patient phenotyping. D. Align the new LUTD symptom measurement tool among involved parties. This workshop is free and open to the public. We encourage registration for those attending in person (see Web address below). Individuals with disabilities who need reasonable accommodations should indicate your needs on the registration form or contact Ms. Mary Compton at The Scientific Consulting Group, Inc. by e-mail at mcompton@scgcorp.com or by telephone to 301–670–4990. For more information, including an agenda, registration and visitor information, please visit the Workshop Web site: https://www2.niddk.nih.gov/ News/Calendar/MOMUS2011. Contact Person: Ziya Kirkali, M.D.; Senior Scientific Advisor, Division of Kidney, Urology and Hematology, NIDDK, NIH. Phone: 301–594–7718 Email: kirkaliz@mail.nih.gov. property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of General Medical Sciences Special Emphasis Panel, Review of Minority Biomedical Research Support Behavioral Applications. Date: October 27, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Courtyard Chevy Chase, 5520 Wisconsin Avenue, Chevy Chase, MD 20815. Contact Person: Rebecca H. Johnson, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18C, Bethesda, MD 20892, 301–594–2771, johnsonrh@nigms.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: September 29, 2011. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–25870 Filed 10–5–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Dated: September 29, 2011. Robert Star, Director, KUH/NIDDK, National Institutes of Health. National Institutes of Health [FR Doc. 2011–25872 Filed 10–5–11; 8:45 am] Part N, National Institutes of Health (NIH), of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services (40 FR 22859, May 27, 1975, as amended most recently at 66 FR 6617, January 22, 2001, and redesignated from Part HN as Part N at 60 FR 56605, November 9, 1995), is amended as set forth below to reflect organizational changes in the National Institute on Minority Health and Health Disparities (NIMHD). Section N–B, Organization and Functions, is amended as follows: Immediately after the paragraph headed ‘‘National Institute of Minority Health and Health Disparities’’ (NE, formerly HNE), insert the following: Office of the Director (OD) (NE 1 formerly HNE 1). Determines and provides leadership to the Institute’s BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health mstockstill on DSK4VPTVN1PROD with NOTICES National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial VerDate Mar<15>2010 16:07 Oct 05, 2011 Jkt 226001 Statement of Organization, Functions, and Delegations of Authority PO 00000 Frm 00049 Fmt 4703 Sfmt 4703 62083 programs, plans, and policies; Provides leadership for the NIH minority health and health disparities research and activities including the implementation of the Minority Health and Health Disparities Research and Education Act (Pub. L. 106–525) and the Patient Protection and Affordable Care Act (Pub. L. 111–148) and other relevant public laws as they relate to the NIMHD mission; Directs an integrated system of coordination for the NIH health disparities research program; Directs the Institute’s development and coordination of minority health and health disparities research programs, activities, and strategic partnerships with the NIH Institutes and Centers, NIH Office of the Director, Federal agencies, State, local, tribal, and regional public health agencies and private entities; Provides leadership for the NIH health disparities strategic plan and budget; Leads the management, communications, legislation, strategic planning, science policy and ethics activities for the Institute; and Provides leadership for developing and revising the national definition for health disparity population in consultation with the Agency for Healthcare Research and Quality. Office of Extramural Research Administration (OERA) (NE 16, formerly HNE 16). Responsible for the administration of the Institute’s extramural research dealing with peer review activities, grants management, extramural grants policy, and ethics issues (patient rights, animal rights, financial conflict of interest, etc.); Facilitates Institute-wide communication and coordination regarding extramural policy, planning, and analysis; Provides advice and guidance to the Director regarding the Institute’s peer and objective review processes as well as NIH extramural programs, policies and procedures; Recommends mechanisms to be used or develops mechanisms to accomplish program objectives; Provides leadership to program, review, and grants management staff in writing solicitations for grants and contracts and reviews funding opportunity announcements for clearance; Develops, implements, and manages integrated policies and procedures affecting all NIMHD extramural activities, and assures appropriate training, information dissemination, and systems for NIMHD extramural staff and the extramural research community; Interprets, advises, and ensures NIMHD staff adherence to and understanding of impact of NIH and Department of Health and Human Services extramural E:\FR\FM\06OCN1.SGM 06OCN1

Agencies

[Federal Register Volume 76, Number 194 (Thursday, October 6, 2011)]
[Notices]
[Pages 62082-62083]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-25872]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Open Meeting

    Notice is hereby given that the National Institute of Diabetes and 
Digestive and Kidney Diseases (NIDDK), a research institute of the 
National Institutes of Health (NIH), Department of Health and Human 
Services (DHHS), plans to hold a scientific meeting.
    Title: ``Meeting on Measurement of Urinary Symptoms (MOMUS).''
    Dates: November 14-15, 2011.

[[Page 62083]]

    Time: 8:30 a.m.-6 p.m.
    Place: Building 45, Natcher Center Main Auditorium, NIH campus, 
Bethesda, MD.
    Meeting Objectives:
    A. Discuss the uses and shortcomings of current symptom-based 
instruments in research of lower urinary tract dysfunction (LUTD).
    B. Disseminate state-of-the-art methodology to improve patient 
reported outcomes (PRO) of symptomatic LUTD.
    C. Discuss the validation and qualification process of new 
measurement tools, and patient phenotyping.
    D. Align the new LUTD symptom measurement tool among involved 
parties.
    This workshop is free and open to the public. We encourage 
registration for those attending in person (see Web address below).
    Individuals with disabilities who need reasonable accommodations 
should indicate your needs on the registration form or contact Ms. Mary 
Compton at The Scientific Consulting Group, Inc. by e-mail at 
mcompton@scgcorp.com or by telephone to 301-670-4990.
    For more information, including an agenda, registration and visitor 
information, please visit the Workshop Web site: https://www2.niddk.nih.gov/News/Calendar/MOMUS2011.
    Contact Person: Ziya Kirkali, M.D.; Senior Scientific Advisor, 
Division of Kidney, Urology and Hematology, NIDDK, NIH. Phone: 301-594-
7718 E-mail: kirkaliz@mail.nih.gov.

    Dated: September 29, 2011.
Robert Star,
Director, KUH/NIDDK, National Institutes of Health.
[FR Doc. 2011-25872 Filed 10-5-11; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.